Minerva Neurosciences
Patents, Design & Utilities

Last updated:

List of all Minerva Neurosciences patents 10 in total

Status Patent
Application
Utility: METHODS OF USE OF CYCLIC AMIDE DERIVATIVES TO TREAT SCHIZOPHRENIA External link
Filling date: 27 Sep 2025 Issue date: 1 Sep 2022
Application
Utility: USE OF ROLUPERIDONE TO TREAT NEGATIVE SYMPTOMS AND DISORDERS, INCREASE NEUROPLASTICITY, AND PROMOTE NEUROPROTECTION External link
Filling date: 27 Sep 2025 Issue date: 31 Mar 2022
Grant
Utility: Use of roluperidone to treat negative symptoms and disorders, increase neuroplasticity, and promote neuroprotection External link
Filling date: 27 Sep 2025 Issue date: 10 Aug 2021
Application
Utility: COMPOSITIONS AND METHODS FOR TREATING SCHIZOPHRENIA External link
Filling date: 27 Sep 2025 Issue date: 29 Jul 2021
Application
Utility: METHODS OF USE OF CYCLIC AMIDE DERIVATIVES TO TREAT SIGMA RECEPTOR MEDIATED DISORDERS External link
Filling date: 27 Sep 2025 Issue date: 15 Apr 2021
Grant
Utility: Compositions and methods for treating schizophrenia External link
Filling date: 27 Sep 2025 Issue date: 13 Oct 2020
Application
Utility: METHODS OF USE OF PHENOXYPROPYLAMINE COMPOUNDS TO TREAT DEPRESSION External link
Filling date: 27 Sep 2025 Issue date: 16 Jul 2020
Application
Utility: METHODS OF USING A PHENOXYPROPYLAMINE COMPOUND TO TREAT PAIN External link
Filling date: 27 Sep 2025 Issue date: 5 Mar 2020
Application
Utility: USE OF ROLUPERIDONE TO TREAT NEGATIVE SYMPTOMS AND DISORDERS, INCREASE NEUROPLASTICITY, AND PROMOTE NEUROPROTECTION External link
Filling date: 27 Sep 2025 Issue date: 27 Feb 2020
Application
Utility: COMPOSITIONS AND METHODS FOR TREATING SCHIZOPHRENIA External link
Filling date: 27 Sep 2025 Issue date: 23 Jan 2020

Showing 1 to 10 of 10 patents.